Skip to content

IBIS 4

Active Private limited companyfounded 1998active for 28 yearsChemin du Grand Sart, Bonlez 12, 1325 Chaumont-GistouxKBO/BCE: BE 0464.375.424 #5 oldest company in Walloon Brabant, Veterinary activities sector

Board

1 director, no change since 2025
Director (not named in the articles)
current term since 13-05-2025 term without a fixed end
listed in the 2026 annual accounts, filed on 15-10-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Chaque administrateur représente la société à l'égard des tiers et en justice, soit en demandant, soit en défendant.”
deed of 03-07-2020

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today

Director (not named in the articles)

Director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
    • Director (not named in the articles), since before 30-06-2024
    • Director (not named in the articles), appointed by deed of 03-07-2020, until 06-02-2025
    • Manager, until 03-07-2020

Control

Capital

Contribution
€1,500
Source
deed of 15-05-2025

Articles of association

deed of 15-05-2025 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
Assemblée générale décide si mandat exercé gratuitement, montant fixé par AG majorité absolue voix ou actionnaire unique fixe ou proportionnelle
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
Moitié cédant moitié acquéreurs proportionnellement si plusieurs, exiger rachat par opposants au prix notifié ou contestation prix fixé par expert commun accord…
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Third Thursday of October at 18:00

Capital transactions

Capital over time
  1. 15-05-2025 Converted to unavailable equity · €1,500
  2. 03-07-2020 Converted to unavailable equity · €20,841.43

Next steps